Brief: Mirati Therapeutics Announces Departure Of Chief Financial Officer Laurie Stelzer
23/08/2023 21:01
Aug 23 (Reuters) - Mirati Therapeutics Inc MRTX.O :
* MIRATI THERAPEUTICS ANNOUNCES DEPARTURE OF CHIEF FINANCIAL
OFFICER LAURIE STELZER
Source text for Eikon: ID:nPn7FpldFa
Further company coverage: MRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mirati Therapeutics
See all newsBrief: European Commission Approves KRAZATI As A Targeted Treatment For Non-Small Cell Lung Cancer
US FDA turns down Amgen lung cancer drug Lumakras for full approval (updated)
US FDA turns down Amgen lung cancer drug Lumakras for full approval
Brief: Mirati Stockholders Voted 'For' Proposal To Adopt Deal Between Co, Bristol-Myers Squibb
Mirati's lung cancer drug gets EU's regulatory backing (updated)